Beijing Northland Biotech Co., Ltd.

Room A406, No.5, Shangdi Kaituo Road, Haidian District, Beijing, 北京市, China

Also known as:

nsld

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

36.4%

Phase 3

36.4%

Phase 1

18.2%

Trial Status Distribution

Completed

72.7%

Enrolling By Invitation

9.1%

Not yet recruiting

9.1%

Recruiting

9.1%

Clinical Trials

Trials sponsored by this organization (11)

Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction

Phase 2

Not yet recruiting

interventional

May 2026189 participants

Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)

Enrolling By Invitation

observational

Jun 2025542 participants

Angiogenesis and Blood Perfusion Effect of HGF Gene Therapy in PAD Patients

Phase 3

Recruiting

interventional

Jul 202236 participants

Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction

Phase 2

Completed

interventional

Jul 202290 participants

Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction

Phase 2

Completed

interventional

Nov 202062 participants

Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2)

Phase 3

Completed

interventional

Aug 2019242 participants

Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-1)

Phase 3

Completed

interventional

Aug 2019302 participants

A Phase 1b Study of Thymosin Beta 4 in Healthy Volunteers

Phase 1

Completed

interventional

Jul 201830 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations